Daniel Palmacci
Corporate Officer/Principal bei MORPHOSYS AG
Vermögen: 32 277 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Daniel Palmacci
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
28
| Public Company | Biotechnology | 28 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Daniel Palmacci
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| FRESENIUS SE & CO. KGAA | Medical Specialties | Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO | |
| VERACYTE, INC. | Medical Specialties | Director/Board Member | |
| Merck KGAA Unsponsored ADR Facility | Corporate Officer/Principal | ||
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member President | |
| NOVARTIS AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Graduate Degree | |
Fresenius Kabi AG
 Fresenius Kabi AG Pharmaceuticals: MajorHealth Technology Fresenius Kabi AG manufactures medical devices for therapies. It specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The firm offers infusion solutions for fluid substitution, blood volume replacement, intravenously administered drugs as well as the respective medical devices for the application, pump systems and infusion management systems. The company was founded in 1999 and is headquartered in Bad Homburg, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Fresenius ProServe GmbH
 Fresenius ProServe GmbH Hospital/Nursing ManagementHealth Services Fresenius ProServe GmbH specializes in the medical business with hospitals and healthcare facilities. Its services range from the planning and construction of hospitals to technical and operational management in its core areas of hospital management and hospital engineering. The company is headquartered in Bad Homburg vor der Höhe, Germany. | Hospital/Nursing Management | Chief Executive Officer | |
| Rutgers State University of New Jersey | College/University | Graduate Degree | |
| University of California, Irvine | College/University | Undergraduate Degree | |
| Universität zu Köln | College/University | Graduate Degree | |
| University of Deusto | College/University | Graduate Degree | |
| University of Zurich | College/University | Doctorate Degree | |
| Freie Universität Berlin | College/University | Doctorate Degree Graduate Degree | |
| The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree | |
| École Normale Supérieure | College/University | Graduate Degree | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member | |
InflaRx GmbH
 InflaRx GmbH BiotechnologyHealth Technology InflaRx GmbH operates as a biotech company which develops new therapeutics in the field of inflammation. It focuses on the general area of inflammation including indications such as SIRS and SEPSIS by applying innovative therapeutics in order to prevent organ dysfunction or limit progression into organ failure. The firm's complement system is activated and produces large amounts of products including complement 5a (C5a), C3a, C4a and membrane-attack complex (MAC). The company was founded in 2007 by Niels Riedemann and Renfeng Guo and is headquartered in Jena, Germany. | Biotechnology | Director/Board Member | |
| BIONTECH SE | Biotechnology | Director of Finance/CFO | |
| QUANTUM GENOMICS | Pharmaceuticals: Major | Director/Board Member | |
Amgen NV
 Amgen NV Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Amgen NV is a pharmaceutical company based in Diegem, Belgium. The Belgian company is focused on developing innovative therapies to address serious illnesses and improve the lives of patients. Amgen is committed to advancing scientific research and delivering high-quality medicines to patients worldwide. The CEO of the company is Gabor Sztaniszlav. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Fresenius Medical Care Management AG
 Fresenius Medical Care Management AG Medical DistributorsDistribution Services Part of Fresenius SE & Co. KGaA, Fresenius Medical Care Management AG is a German company that provides innovative products, therapies, and services to create a livable future for their patients. The company is based in Bad Homburg, Germany. The company specializes in chronic and acute kidney dialysis and therapeutic apheresis. The company was founded in 2005. The CEO is Helen Giza. | Medical Distributors | Director of Finance/CFO | |
Sanofi Pasteur MSD SNC
 Sanofi Pasteur MSD SNC Pharmaceuticals: MajorHealth Technology Sanofi Pasteur MSD SNC is engaged in the wholesale of pharmaceutical products. The company was founded on August 16, 1993 and is headquartered in Lyon, France. | Pharmaceuticals: Major | Chief Executive Officer | |
Hospitalia International GmbH
 Hospitalia International GmbH Medical/Nursing ServicesHealth Services Part of Else Kröner-Fresenius-Stiftung, Hospitalia International GmbH is a German company that provides health care and other related services. The company is based in Bad Homburg, Germany. The CEOs of the company are Mirsad Midzic, Jens K. Schäkel, Rafael Garcia Feil. | Medical/Nursing Services | Corporate Officer/Principal | |
| University of Antwerp | College/University | Graduate Degree | |
Fresenius Kabi Asia Pacific Ltd.
 Fresenius Kabi Asia Pacific Ltd. Medical DistributorsDistribution Services Part of Fresenius SE & Co. KGaA, Fresenius Kabi Asia Pacific Ltd. is a Chinese healthcare company that was founded in 2001. The company is based in Hong Kong, Hong Kong and specializes in providing lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. Fresenius Kabi is committed to making essential medicines and technologies accessible to healthcare professionals who help patients. | Medical Distributors | Corporate Officer/Principal | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Director of Finance/CFO | |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| INFLARX N.V. | Biotechnology | Director/Board Member | |
| HOOKIPA PHARMA INC. | Biotechnology | Director/Board Member | |
| Faculté De Médecine Necker Enfants Malades Université | College/University | Doctorate Degree | |
| TANGO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Human Immunology Biosciences, Inc.
 Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
| Hospitalia Care Gmbh | Corporate Officer/Principal | ||
Fresenius Kabi Deutschland GmbH
 Fresenius Kabi Deutschland GmbH Pharmaceuticals: GenericHealth Technology Part of Fresenius SE & Co. KGaA, Fresenius Kabi Deutschland GmbH is a healthcare company based in Bad Homburg vor der Hohe, Germany. The CEOs are Steffen Roser, Christoph Funke, Tanja Greve. Fresenius Kabi creates an environment of mutual respect, encouragement, and teamwork. The German company specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company is also specialized in the field of oncology products supported by integrated manufacturing, regulatory, sales, marketing & distribution set up. The company has summarized their expectations towards their suppliers and business partners in a suppliers code of conduct and a business partner code of conduct. The company was founded in 1999. | Pharmaceuticals: Generic | Chief Executive Officer |
Statistik
International
| Deutschland | 21 |
| Vereinigte Staaten | 19 |
| Frankreich | 7 |
| Schweiz | 3 |
| Belgien | 3 |
Sektoral
| Health Technology | 32 |
| Consumer Services | 13 |
| Health Services | 4 |
| Distribution Services | 3 |
Operativ
| Director/Board Member | 61 |
| Corporate Officer/Principal | 60 |
| Independent Dir/Board Member | 24 |
| Graduate Degree | 13 |
| Director of Finance/CFO | 12 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| George Golumbeski | 36 |
| Wendy Johnson | 23 |
| Michael Brosnan | 14 |
| Sharon Curran | 14 |
| Jens Holstein | 14 |
| Malte Peters | 11 |
| Jean-Paul Kress | 10 |
| Andrew Cheng | 10 |
| Ann Merchant | 8 |
| Krisja Vermeylen | 8 |
| Marc Cluzel | 8 |
| Sung Lee | 7 |
| Tim Demuth | 5 |
| Barbara Krebs-Pohl | 5 |
| Maria Castresana | 5 |
- Börse
- Insiders
- Daniel Palmacci
- Unternehmensverbindungen
